Drug Chatter -- Tracking biopharma stock chatter

Profile for Flexion Therapeutics, Inc. (FLXN)

« Back to company index

FLXN Chatter Timeline

Stock Ticker for FLXN

Most Active Tweeters for FLXN

UserTweets
@TheMarketsDaily 3
@TranscriptDaily 3
@1MinuteStock 3
@ledgerzette 2
@RevShark 2

Recent Tweets for FLXN

MariaDa18810214 @MariaDa18810214
Nicholas Investment Partners LP Position in Flexion Therapeutics $FLXN Lowered as Share Value Declined ...
January 14th 2018, 6:01am
AmericanBanking @AmericanBanking
Flexion Therapeutics Inc $FLXN Given Average Rating of “Buy” by Brokerages https://t.co/cPQyR5Af9u #stocks
January 12th 2018, 5:01pm
WeekHerald @WeekHerald
Flexion Therapeutics Inc $FLXN Given Average Rating of “Buy” by Brokerages https://t.co/2uqpNI1lMm
January 12th 2018, 5:01pm
TheMarketsDaily @TheMarketsDaily
Flexion Therapeutics $FLXN Upgraded at Zacks Investment Research https://t.co/ERQ83sybaP
January 12th 2018, 2:01pm
RevShark @RevShark
You can't reason with a steamroller and bulking up a position in $FLXN https://t.co/mSDbJ1fblp @jimcramer @DougKass https://t.co/aZMERiHTRd
January 12th 2018, 1:01pm
RevShark @RevShark
Adding to our position in $FLXN today at https://t.co/JDBIgRQ8qv
January 12th 2018, 11:01am
tymorapro @tymorapro
$FLXN: Exc 1WkHIGH=26.50, hits:1, Rng:7%, ch:+2.0%, 1NewHi, allTFs+, medFlt:33M, HiPctSht[31%:12d], DyVol:188T:0.3x… https://t.co/BvhS30i3rE
January 12th 2018, 10:01am
WatchlistN @WatchlistN
Flexion Therapeutics $FLXN Raised to Hold at Zacks Investment Research https://t.co/oe5MZjvmf2
January 11th 2018, 11:01am
TranscriptDaily @TranscriptDaily
Somewhat Positive Media Coverage Somewhat Unlikely to Affect Flexion Therapeutics $FLXN Stock Price https://t.co/VPGNiRkuqH
January 11th 2018, 9:01am
Margare30926081 @Margare30926081
Commonwealth Of Pennsylvania Public School Empls Retrmt Sys Position in Flexion Therapeutics $FLXN Has Lowe...
January 11th 2018, 9:01am
TranscriptDaily @TranscriptDaily
Berson & Corrado Investment Advisors LLC Buys New Position in Flexion Therapeutics Inc $FLXN https://t.co/JrcX7WqBO2
January 10th 2018, 7:01pm
dispatchtribune @dispatchtribune
Flexion Therapeutics $FLXN Upgraded by Zacks Investment Research to Hold https://t.co/ocolNLMLZT
January 10th 2018, 5:01pm
OlympiaReport @OlympiaReport
Flexion Therapeutics $FLXN Upgraded at Zacks Investment Research https://t.co/LGtjvp5M26
January 9th 2018, 11:01pm
TribuneTrueBlue @TribuneTrueBlue
Flexion Therapeutics $FLXN Upgraded at Zacks Investment Research https://t.co/VlSrVlNqyn
January 9th 2018, 11:01pm
algonell @algonell
$FLXN Bullish Signal, Proba: above 90% , Forecast: 3 months https://t.co/H0p3YJ7NWh
January 9th 2018, 10:01pm
intercooleronli @intercooleronli
Flexion Therapeutics Inc $FLXN Holdings Lessened by Wells Fargo & Company MN https://t.co/eyJH5nCgWp #investing
January 9th 2018, 8:01am
theflynews @theflynews
Wells Fargo says Flexion repeat dosing data for Zilretta encouraging: https://t.co/mJbdhriWJW $FLXN
January 8th 2018, 12:01pm
Briefingcom @Briefingcom
$FLXN: Flexion Therapeutics announces initial findings from its ongoing Phase 3b, open-label study to evaluate the.… https://t.co/eXM3Aj5sLk
January 8th 2018, 9:01am
SwingTradeBot @SwingTradeBot
Recent $FLXN technical alerts: MACD Bearish Signal Line Cross plus 3 more alerts... https://t.co/0FnmGRrEf6
January 8th 2018, 9:01am
1MinuteStock @1MinuteStock
Do you know that #WallStreet price for $FLXN is $39.5 https://t.co/8VMORiwZLM
January 8th 2018, 8:01am
StockNewsWires @StockNewsWires
$FLXN: Flexion’s Zilretta shows treatment benefit in late-stage OAK study …: https://t.co/z85kmnc7fl
January 8th 2018, 7:01am
MarketCurrents @MarketCurrents
Flexion's Zilretta shows treatment benefit in late-stage OAK study evaluating second injection https://t.co/cIygaM5u7Q #premarket $FLXN
January 8th 2018, 7:01am
SEEKINGALPHA_FS @SEEKINGALPHA_FS
Flexion's Zilretta shows treatment benefit in late-stage OAK study evaluating second injection https://t.co/nLxgIIOeal #premarket $FLXN
January 8th 2018, 7:01am
stocknewsdotcom @stocknewsdotcom
$FLXN Announces initial findings from its ongoing Phase 3b, open-label study to evaluate the repeat administration… https://t.co/a1mUlXngJv
January 8th 2018, 7:01am
ProTradersNews @ProTradersNews
$FLXN: Flexion Therapeutics (FLXN) Reports Initial Data from Clinical Trial …: https://t.co/H70ZGUtLfU
January 8th 2018, 7:01am
portefeuillefun @portefeuillefun
RT @odibro: $FLXN Announces Initial Data from Clinical Trial Evaluating Repeat Administration of ZILRETTA™ https://t.co/EkVMlm4hU2
January 8th 2018, 7:01am
odibro @odibro
$FLXN Announces Initial Data from Clinical Trial Evaluating Repeat Administration of ZILRETTA™ https://t.co/EkVMlm4hU2
January 8th 2018, 7:01am
stockboardinc @stockboardinc
$FLXN Flexion Therapeutics Announces Initial Data from Clinical Trial Evaluating Repeat Administration of ... - https://t.co/2P89XKrGIO
January 8th 2018, 7:01am
livetraderalrt @livetraderalrt
$FLXN 2.2m ago: Flexion Therapeutics Announces Initial Data from Clinical Trial Evaluating Repeat Administration of… https://t.co/WCiRwsiBYD
January 8th 2018, 7:01am
GNWLive @GNWLive
Flexion Therapeutics Announces Initial Data from Clinical Trial Evaluating Repeat Administration of $FLXN https://t.co/AN06GV1Lwh
January 8th 2018, 7:01am
FlexionInc @FlexionInc
We’re ready for a busy week in San Francisco at the 36th Annual JP Morgan Healthcare Conference #JPM18 $FLXN… https://t.co/QblojIKnJ2
January 7th 2018, 5:01pm
ChartMill @ChartMill
Besides having an excellent technical rating, $FLXN also presents a decent setup pattern. We see reduced volati ...… https://t.co/p9lNaXuur3
January 6th 2018, 8:01pm
TheMarketsDaily @TheMarketsDaily
Somewhat Favorable News Coverage Somewhat Unlikely to Impact Flexion Therapeutics $FLXN Share Price https://t.co/M5Yy2BEzqV
January 6th 2018, 10:01am
ledgerzette @ledgerzette
Somewhat Favorable News Coverage Somewhat Unlikely to Impact Flexion Therapeutics $FLXN Share Price https://t.co/6Mg3MUu1ac
January 6th 2018, 10:01am
ledgerzette @ledgerzette
Zacks: Brokerages Anticipate Flexion Therapeutics Inc $FLXN Will Announce Quarterly Sales of $1.29 Million https://t.co/XDZyCxds4u
January 6th 2018, 7:01am
AmericanBanking @AmericanBanking
Zacks: Brokerages Anticipate Flexion Therapeutics Inc $FLXN Will Announce Quarterly Sales of $1.29 Million https://t.co/tmjM5CFYe4 #stocks
January 6th 2018, 4:01am
ZolmaxNews @ZolmaxNews
Zacks: Brokerages Anticipate Flexion Therapeutics Inc $FLXN Will Announce Quarterly Sales of $1.29 Million https://t.co/o6tj6D1eQ3
January 6th 2018, 4:01am
TranscriptDaily @TranscriptDaily
Flexion Therapeutics $FLXN Downgraded by Zacks Investment Research to Sell https://t.co/N1AayzqgNA
January 5th 2018, 2:01pm
MarginHunt @MarginHunt
Flexion Therapeutics, $FLXN could lower your stock returns. Scores only a 1 via Piotroski's F-Score https://t.co/10Ue00O2Sx
January 5th 2018, 2:01am
Atlas95_Atlas @Atlas95_Atlas
$FLXN increased our position by 33% @ 25.30. These are trading shares. “Define Your Future”
January 4th 2018, 10:01am
wosaikeneriki @wosaikeneriki
Flexion Therapeutics $FLXN Stock Declined While Gsa Capital Partners Llp Lowered Stake https://t.co/j19iBnTLPw
January 4th 2018, 6:01am
wosaikeneriki @wosaikeneriki
Lmm Boosted Flexion Therapeutics $FLXN Stake by $15.68 Million as Stock Declined https://t.co/TlPFcIUl8h
January 4th 2018, 5:01am
MariaDa18810214 @MariaDa18810214
Flexion Therapeutics, Inc. $FLXN Reaches $25.81 After 7.00% Down Move https://t.co/tJATPBY0ez
January 3rd 2018, 12:01pm
filingBot @filingBot
@altafmubaraki there is a new form 3/A filing for $FLXN https://t.co/Z5Q9FDcsKb Likes and RTs apprechiated
January 2nd 2018, 4:01pm
1MinuteStock @1MinuteStock
Wondering about #sentiment indicator for $FLXN? The Short Ratio is 6.06% https://t.co/czlSA3vnbp
January 2nd 2018, 2:01pm
1MinuteStock @1MinuteStock
Not sure what to do with $FLXN? Explore our #fundamental pros and cons. https://t.co/TO3nGvQMd8
January 2nd 2018, 2:01pm
SwingTradeBot @SwingTradeBot
Recent $FLXN technical alerts: Bollinger Band Squeeze plus 2 more alerts... https://t.co/0FnmGRrEf6
January 2nd 2018, 2:01pm
WeekHerald @WeekHerald
Flexion Therapeutics Inc $FLXN Receives Consensus Rating of “Buy” from Analysts https://t.co/DS5EEETczw
January 2nd 2018, 2:01pm
tymorapro @tymorapro
$FLXN: Exc 1DyHIGH=25.91, hits:3, ch:+3.5%, 0phNewHi:BrkPLo+PHi[+4.7%], 26:3Accel+, tf:1001111, medFlt:33M, HiPctSht[31%:11d]
January 2nd 2018, 10:01am
TheMarketsDaily @TheMarketsDaily
Flexion Therapeutics $FLXN Stock Rating Upgraded by ValuEngine https://t.co/AI4GAgVC8H
January 2nd 2018, 5:01am

Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.